focus -WSS

focus

author：entertainment 2025-10-03 00:08:15 - browse：8

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Biotech companies concerned about China biosecurity crackdown

leisure time

WSS

NVIDIA and Google execs on the future of AI and drug discovery

Kenai launches with $82 million for Parkinson’s stem cell therapy

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Military medical care influenced by rank and race, new study finds

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

leisure time

focus

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

When prostate cancer spreads, where it goes matters

Malaria cases in Florida and Texas: Here’s what you need to know

Venture capitalist Bob Kocher on the state of digital health

How to save PrEP access — and even expand it

In search for therapies for solid tumors, companies turn to claudin

Apple is now the first public company to be valued at $3 trillion

Why getting cancer drugs just got harder for rural patients

Apple is now the first public company to be valued at $3 trillion

Why getting cancer drugs just got harder for rural patients

hotspot

HIV vaccine remains elusive. Immunologists keep trying new ideas

Congress gives doctors Medicare pay bump

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

FogPharma raises $145 million in rare Series E round

Congress gives doctors Medicare pay bump

With measles on the rise, a personal story of a devastating disease

leisure time

hotspot

leisure time

leisure time